iPLEX® HS Melanoma Panel: Enhancing Melanoma Genetic Analysis

Melanoma is a type of skin cancer that needs detailed genetic analysis for effective treatment. The iPLEX® HS Melanoma Panel is a tool that’s improving how this testing is done, offering a more efficient and thorough approach.

Balancing Comprehensive Detection and Sensitivity

A common challenge in genetic testing is the need to cover a wide range of genetic targets while also picking up rare mutations. The iPLEX® HS Melanoma Panel, utilizing MassARRAY technology, effectively manages this by enabling the detection of a broad array of mutations without missing the less frequent ones.

Wide-Ranging Mutation Detection

The panel is capable of identifying over 100 clinically relevant variants, including those with as low as 1% mutant allele frequency. This includes detecting variants in genes such as BRAF, KIT, NRAS, TERT, and more, providing a comprehensive overview in melanoma cases. This wide range helps give a full picture of the genetic changes in melanoma.

Versatility with Various Sample Types

The ability to process a variety of sample types, even those of lower quality like FFPE tissue or needle biopsies, is a key feature of the iPLEX® HS Melanoma Panel. This flexibility is particularly valuable in clinical settings where sample quality can vary.

Efficient and Streamlined Process

One of the main advantages of this panel is its efficiency, delivering results in as little as 8 hours with 1 hour hands on time. This quick turnaround is essential in clinical environments where timely decision-making can impact treatment outcomes.

Conclusion

The iPLEX® HS Melanoma Panel is a development in melanoma diagnostics. Its comprehensive, sensitive, and efficient approach to genetic testing, along with its adaptability to different sample types, makes it an valuable resource in the clinical laboratories. By providing detailed and accurate genetic insights, It helps in creating better treatment plans, leading to improved care for people with melanoma.